# Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

> **NCT06511726** · PHASE2 · RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 29 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Cadonilimab

## Key facts

- **NCT ID:** NCT06511726
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-23
- **Primary completion:** 2025-10-30
- **Final completion:** 2027-10-30
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2025-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06511726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06511726, "Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06511726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*